| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, COO &Interim CEO | President and COO
1 company
Cohlhepp Ryan is a President, COO &Interim CEO at BCAX. Recent filings cover 0 purchases and 29 sales. Those positions are worth an estimated $688K at current prices.
Our model assigns Cohlhepp Ryan a middling insider score of 52/100, based on 7 past trades. On a 3-month view, 57.1% of the rated trades came out ahead, averaging -0.1% over three months.
Cohlhepp Ryan's largest disclosed position is in BCAX as President, COO &Interim CEO, worth about $688K. The recent filings there lean toward selling, a net 215,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 12,500 | $18.68 | $233,547.50 | -6.2% | +5.7% | - | |
| Nov 21, 2025 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 12,500 | $18.05 | $225,587.50 | -6.1% | -14.5% | - | |
| Oct 15, 2025 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 12,500 | $18.16 | $226,942.50 | -5.9% | -6.8% | -6.3% | |
| Oct 7, 2025 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 50,500 | $18.06 | $911,841.99 | -19.9% | -11.3% | -9.6% |